The Carterra LSA helped AbCellera and Eli Lilly evaluate binding affinity and epitope coverage for over 500 patient-derived antibodies, including LY-CoV555. The LSA, a high-throughput monoclonal antibody characterization platform, combines microfluidic flow technology and high-throughput surface plasmon resonance detection.